Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

103.89 +0.05 (+0.04%)
Streaming Delayed Price Updated: 3:42 PM EDT, Mar 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,156,536
Open 103.70
Bid (Size) 103.89 (200)
Ask (Size) 103.90 (1,600)
Prev. Close 103.85
Today's Range 103.68 - 104.00
52wk Range 38.81 - 103.92
Shares Outstanding 171,948,769
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
1 Mid-Cap Stock to Consider Right Now and 2 Facing Headwinds
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man... 
Via StockStory
News headline image
Hedge Fund Beryl Capital Initiated a Position in CSG Systems Worth Over $54 Million. Is the Stock a Buy? ↗
CSG Systems International delivers SaaS-based billing and customer engagement solutions to telecom and enterprise clients worldwide. 
Via The Motley Fool

Performance

YTD
+2.1%
+2.1%
1 Month
+0.6%
+0.6%
3 Month
+2.1%
+2.1%
6 Month
+94.5%
+94.5%
1 Year
+130.0%
+130.0%

More News

Read More
News headline image
Macroeconomic Headwinds and Shifting Demand Force Healthcare Giants to Trim 2026 Outlooks
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
EXACT SCIENCES CORP (NASDAQ:EXAS) Shows Strong Technical and Fundamental Momentum ↗
Via Chartmill
News headline image
3 Cash-Producing Stocks We Approach with Caution
Via StockStory
News headline image
The Return of the Titans: M&A Volume Set to Surge 20% in 2026 Amidst "Animal Spirits"
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year
From Exact Sciences Corp.
Via Business Wire
News headline image
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration
From Amalgam Rx, Inc.
Via Business Wire
News headline image
Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time ↗
Via The Motley Fool
Topics Cannabis Initial Public Offering
News headline image
Medtronic Hits 10-Quarter High: PFA Dominance and Robotic Surges Signal a New Era for MedTech
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
Exact Sciences Stockholders Approve Acquisition by Abbott
From Exact Sciences Corp.
Via Business Wire
News headline image
Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape
Via MarketMinute
News headline image
3 Unpopular Stocks We Approach with Caution
Via StockStory
Topics Economy
News headline image
3 Overrated Stocks That Concern Us
Via StockStory
News headline image
Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results
From Exact Sciences Corp.
Via Business Wire
News headline image
Abbott Labs: The Healthcare Dividend Stock I'd Happily Hold Forever ↗
Via The Motley Fool
News headline image
Halper Sadeh LLC is Investigating Whether CTRA, EXAS, NFBK are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Northfield Bancorp Inc. (Nasdaq - NFBK), Coterra Energy Inc. (NYSE - CTRA), Exact Sciences Corporation (Nasdaq – EXAS), Semrush Holdings, Inc. (NYSE – SEMR)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
1 Momentum Stock with Exciting Potential and 2 Facing Headwinds
Via StockStory
News headline image
Exact Sciences (EXAS): Buy, Sell, or Hold Post Q3 Earnings?
Via StockStory
News headline image
The Era of the Titans: Q4 2025 Mega-Deal Surge and the 2026 Economic Map
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
1 Growth Stock to Stash and 2 We Avoid
Via StockStory
Topics Climate Change
News headline image
Halper Sadeh LLC is Investigating SKYT, EXAS, GORO, MOVE on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests
From Exact Sciences Corp.
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Northfield Bancorp Inc. (Nasdaq - NFBK), Coterra Energy Inc. (NYSE - CTRA), Exact Sciences Corporation (Nasdaq – EXAS), Semrush Holdings, Inc. (NYSE – SEMR)
From Brodsky & Smith LLC
Via GlobeNewswire

Frequently Asked Questions

Is Exact Sciences Corporation - Common Stock publicly traded?
Yes, Exact Sciences Corporation - Common Stock is publicly traded.
What exchange does Exact Sciences Corporation - Common Stock trade on?
Exact Sciences Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Exact Sciences Corporation - Common Stock?
The ticker symbol for Exact Sciences Corporation - Common Stock is EXAS on the Nasdaq Stock Market
What is the current price of Exact Sciences Corporation - Common Stock?
The current price of Exact Sciences Corporation - Common Stock is 103.89
When was Exact Sciences Corporation - Common Stock last traded?
The last trade of Exact Sciences Corporation - Common Stock was at 03/17/26 03:42 PM ET
What is the market capitalization of Exact Sciences Corporation - Common Stock?
The market capitalization of Exact Sciences Corporation - Common Stock is 17.86B
How many shares of Exact Sciences Corporation - Common Stock are outstanding?
Exact Sciences Corporation - Common Stock has 18B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.